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The Eurasian lynx (subspecies Lynx lynx carpathicus) was reintroduced to Switzerland in
the 1970’s. Health monitoring of the reintroduced population started in the late 1980’s.
Since then, six lynx have been found affected by a myocardial disease. The earliest
case was an animal that died after a field anesthesia. Two lynx were found dead,
two were euthanized/culled because of disease signs, and one was hit by car. Two
had a heart murmur at clinical examination. At necropsy, the first animal showed only
lung edema but the other five had cardiomegaly associated with myocardial fibrosis.
Three had multisystemic effusions. Histological examination of all six lynx showed
mild to severe, multifocal, myocardial interstitial and perivascular fibrosis along with
multifocal myocyte degeneration and loss, and replacement fibrosis. Moderate to severe
multifocal arteriosclerosis with associated luminal stenosis of the small andmedium-sized
intramural coronary arteries and the presence of Anitschkow cells was also observed. The
heart lesions may have led to sudden death in the first case and to a chronic right-sided
heart failure in the remaining. None of the lynx showed lesions or signs suggestive of
an acute or subacute infection. Given the common geographic origin of these animals
and the severe loss of heterozygocity in this population, a genetic origin of the disease
is hypothesized.
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INTRODUCTION
Cardiovascular disease is considered the leading cause of mortality in people worldwide (1).
Spontaneous cardiomyopathies have been described in multiple domestic animals such as dogs,
cats, cattle and pigs (2–4), as well as in a wide range of wild animal species, from reptiles to
non-human primates (5–10). Among felids, the domestic cat is known to be particularly prone
to develop cardiomyopathies, and it was proposed as a model for human disease (11). By contrast,
descriptions of cardiac muscle disorders in wild felids are rare (12).
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In both domestic animals and humans, the term
cardiomyopathy has been long used to refer to idiopathic
myocardial disorders, but cardiomyopathies were subsequently
defined as clinicopathological entities resulting either from
genetic anomalies or from nutritional deficiencies, with
cardiomegaly and myocardial fibrosis as most typical features
(13). Meanwhile, definitions have evolved and, based on
the literal meaning of the word (heart muscle disease), the
American Heart Association has proposed a classification system
including primary (heart disease only) and secondary (systemic
disease with cardiac involvement) cardiomyopathies (14). Most
recently, veterinary cardiologists have published a consensus
document on the classification of cardiomyopathies in cats, in
which they define cardiomyopathy as a “myocardial disorder
in which the heart muscle is structurally and functionally
abnormal in the absence of any other cardiovascular disease
sufficient to cause the observed myocardial anomaly.” They
recommend the further use of the formerly described four
main forms of cardiomyopathies but to consider them
different disease phenotypes rather than different disease
forms (15): (1) dilated (congestive) cardiomyopathy (DCM),
characterized by enlargement and dilation of both atria and
ventricles with normal or reduced ventricular wall thickness;
(2) hypertrophic cardiomyopathy (HCM), typically featured by
a wide phenotypic variability of left ventricular hypertrophy
with reduced lumen size, increased absolute and relative heart
weight, hypertrophic papillary muscles and stiff wall. Atrial
dilation, right ventricular hypertrophy, pulmonary edema and
pleural effusion may be present. Myocyte disarray is the gold
standard for histopathological HCM diagnosis but variable
degrees of coronary arteriosclerosis and replacement fibrosis
are also common; (3) restrictive cardiomyopathy (RCM),
characterized by bilateral atrial dilation with ventricles of normal
size with a prominent bridging endocardial scar within the left
ventricle; (4) arrhythmogenic right ventricular cardiomyopathy
(ARVC), characterized by a severe right atrial and ventricular
dilation, frequently with right ventricular wall thinning. Cases
with overlapping features or not fitting well into any category
can be referred to as unclassified cardiomyopathies or as
cardiomyopathies with a non-specified phenotype (13, 15–17).
The most common type of cardiomyopathy and frequent
cause of morbidity and mortality in domestic cats is HCM.
This disease concerns mainly older cats and is often associated
with a loud systolic heart murmur. Although it frequently
remains subclinical, a majority of affected cats develop
congestive heart failure, others arterial thromboembolism,
and a minority die unexpectedly in absence of clinical signs
(15, 18–20). In humans, the definition of cardiomyopathy
formerly excluded coronary arterial or other vascular
disorders (13). Nevertheless, inherited HCM was shown to
be associated with an increased wall/lumen ratio in small
arterioles, predisposing patients to ischemia and subsequent
myocardial fibrosis, with these changes evolving for years before
the onset of symptoms (21). Similarly to cats, disease is often
subclinical, and possible outcomes include sudden death, which
typically occurs in apparently healthy young patients during
physical exercise, thromboembolic events, and chronic heart
failure (22).
The Eurasian lynx (Lynx lynx) is a wild felid endemic to
Europe and North-central Asia, which has undergone a massive
population reduction in Europe in the 19th century (23). Despite
major conservation efforts including reintroduction programs,
many local populations remain small and fragile, and human
persecution together with other anthropogenic factors continue
to pose a serious threat to the long-term survival of this large
carnivore (23–25). Furthermore, only a very limited number of
individuals were released in all reintroduction projects, causing
severe genetic bottlenecks that may have yet unknown impacts
on the fitness of the reintroduced populations (26, 27). In this
context, knowledge of causes of mortality and emerging diseases
of infectious and non-infectious origin in Eurasian lynx, in
relation to population size and status, is essential.
The Carpathian lynx (L. lynx carpathicus), which currently
only occurs in small fragmented populations in Western, Central
and Eastern Europe, is one of the nine currently proposed
Eurasian lynx subspecies (28), of which three others occur in
Europe: theNorthern or Boreal lynx (L. lynx lynx) in Scandinavia,
Finland and European Russia, the Balkan lynx (L. lynx martinoi)
in the Balkan region and the Caucasian lynx (L. lynx dinniki) in
Turkey. Although the separation into these subspecies remains
controversial (29, 30) and genetic differences among subspecies
and populations may be due to epigenetic changes driven by
local environmental characteristics, the existence of differences
are undisputable (27, 28) and associated with varying phenotype
characteristics, such as body size and weight, coat pattern and
skull shape, as well as varying life history traits (28, 31, 32).
Here we report previously undescribed cardiac disorders
characterized by myocardial fibrosis and intramural coronary
arteriosclerosis in six free-ranging Carpathian lynx from a
reintroduced population in Switzerland.
MATERIALS AND METHODS
All lynx included in this study were free-ranging dead animals
submitted to the Centre for Fish and Wildlife Health of the
University of Bern (FIWI) for post-mortem examination in
the framework of the lynx health monitoring program in
Switzerland (33). Accordingly, no ethical permit was required
for the post-mortem study. Four lynx died spontaneously in
nature. One was culled by a professional state game warden
in accordance with the Swiss federal law on hunting practices
and protection of free-ranging wild mammals and birds (nr.
922.0). Another lynx was euthanized by a veterinarian because
of severe debilitation. Capture and marking procedures were
performed with authorizations obtained in the framework of
ecological projects (34–36). The presence of a veterinarian at
wildlife captures is not required by the Swiss legislation and
the inclusion of a wildlife veterinarian in the lynx capture team
dates back to 2000, meaning that only case 3 and 5 underwent
clinical examination. However, no veterinarian participated in
the last capture of case 3, for which a video and clinical records
were made by trained biologists and the records subsequently
evaluated by a veterinarian.
The lynx population in the northwestern Swiss Alps originated
from probably <10 of the 26 individuals released in Switzerland
in the 1970’s (28, 37). The local population in the northwestern
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TABLE 1 | Semiquantitative scoring scheme for arteriosclerosis, myocardial
fibrosis, and Anitschkow cell presence in histological sections of the heart of six
Eurasian lynx (subspecies Lynx lynx carpathicus) from Switzerland affected by
cardiomyopathy.
Feature Grade Definition
Arteriosclerosisa 1 ≤ 5 vessels mildly to moderately affected
2 ≤ 5 vessels moderately to severely
affected, or > 5 vessels but < 50% of the
vessels mildly to moderately affected
3 > 50% of the vessels mildly to severely
affected
Myocardial fibrosis 1 Thin strands of collagen expanding
between myocytes
2 Thicker collagen bands up to small areas
of replacement fibrosis
3 Large amounts of collagen deposits,
including large areas of replacement
fibrosis
Anitschkow cellsb 1 ≤ 5
2 6–15
3 > 15
a If there was a marked variability among the available sections, intermediate grades
were given.
bNumber of cells per HPF in an area with obvious tissue changes.
part of the Swiss Alps is isolated and presently consists of
50–70 independent lynx (38). According to the Swiss Lynx
Management Plan, all lynx found dead or culled because of
compromised health must be submitted to the Centre for Fish
and Wildlife Health (FIWI) at the University of Bern for an
in-depth, standardized post-mortem examination following a
protocol in place since 2002 (33, 39).
Six lynx older than 1 year and of both sexes submitted for
necropsy to the FIWI between 1988 and 2014 were included in
this study. The four most recent cases were examined by the
authors and documented with photographs. The two earliest
cases were retrieved from the archives. Selection criterion was
the record of information suggestive of cardiomyopathy in
the case history, macroscopic pathologic observations and/or
histological descriptions. Lynx were aged as accurately as
possible by cementum annuli counts, tooth wear evaluation and
body measurements, and placed into age classes as previously
described (40, 41).
Since there are no published reference values for the
morphology of the Carpathian lynx heart, and those generated
for Northern lynx do not include the ratios necessary to
overcome body size and weight differences (28, 42), a
healthy individual from Switzerland, originally taken into a
rehabilitation station as an orphan and roadkilled after its
release, was used as a “control” animal for comparison (Table 1,
Figure 1). Repeated auscultation performed under anesthesia
with medetomidine and ketamin (39) did not reveal any
anomaly. Findings were recorded using an electronic stethoscope
(3MTMLittmann R© 3200) and later confirmed by a board-certified
cardiologist. Physical examination, hematology and blood
chemistry, radiographs of the thorax and echocardiography
in clinical settings, as well as pathological examination after
traumatic death (necropsy and histology) were also consistent
with a healthy heart.
For the five most recent cases and the control, morphological
heart data recorded post-mortem included heart weight (g)
and ventricular wall thickness (mm). The right ventricular free
wall, interventricular septum and left ventricular free wall were
measured on a transverse cross section (perpendicular to the long
axis of the ventricles) from the epicardium to the endocardium,
excluding papillary muscles, as a single measurement, using a
millimeter rule. This procedure was the same as reported in
domestic cats (16) except that for lynx the measurements were
made on a cross section located half instead of a third of the
distance from the apex to the base, similarly to a study comparing
cats and rhesus macaques (Macaca mulatta) (43).
Representative samples of the lung, heart, kidneys (case 1–6,
control); liver, spleen, genital organs (case 2–6, control); stomach,
intestine (case 3–6, control), adrenals (case 3–6); lymph nodes
(case 3, 4, and 6); skeletal muscle (case 3–5, control); pancreas
(case 2 and 4); thyroid (case 4 and 5); urinary bladder (case 4
and 6, control); and brain (case 5) were collected and fixed in
10% neutral-buffered formalin. Tissues were then embedded in
paraffin, sectioned at 5µm and stained with hematoxylin and
eosin (H&E) for histologic examination following the accredited
protocols of the Institute of Animal Pathology, Vetsuisse Faculty,
University of Bern. Archived paraffin blocks and/or histological
sections were available for case 2–6. Additional heart sections
were stained using the Masson’s trichrome (MT) and Van Gieson
(VG) protocols for a qualitative and semi-quantitative evaluation
of collagen proliferation and vascular changes.
Histological assessment of the available heart sections was
performed with board-certified pathologists, focusing on the
left free ventricle wall and septum, which were shown to be
more severely affected than the right free ventricle wall in a
preliminary retrospective histological study (44). The two main
pathological features (arteriosclerosis and myocardial fibrosis)
were graded separately according to an arbitrarily defined set
of features. The grading for arteriosclerosis took both the
number of affected vessels and the severity of the arterial
wall thickening into account. Changes were classified based on
their severity and ranged from mild (minor expansion of the
media and/or subintimal collagen deposits) to severe (obvious
luminal stenosis). Myocardial fibrosis was either perivascular,
interstitial, or variably extensive with replacement of myocytes,
or combinations of these. Like for arteriosclerosis, grading of the
myocardial fibrotic changes was based on subjective assessment
of the amount of collagen deposits. The number of Anitshkow
cells per high power field was counted in an area with obvious
tissue changes (Table 1).
RESULTS
Animal Demographics and Clinical History
General information on the six cases and the control are given
in Table 2. All cases came from the same geographical area in
the northwestern part of the Swiss Alps, while the control was
found in the Jura Mountains, a separate population across the
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FIGURE 1 | Normal heart, Eurasian lynx (Lynx lynx carpathicus); (A) right lateral view, (B) diaphragmatic view, (C) left lateral view, and (D) cross-section. Dark
coloration is a freezing artifact.
TABLE 2 | General information on six Eurasian lynx (subspecies Lynx lynx carpathicus) from Switzerland affected by cardiomyopathy and one healthy individual (control)
for comparison.
Parameters Case 1 Case 2 Case 3 Case 4 Case 5 Case 6 Control
Year of death 1988 1991 2003 2012 2013 2014 2015
Circumstances of death Found dead Found dead Found dead Culled Euthanized Hit by car Hit by car
Captured at least once Yes No Yes Yes Yes No Yes
Sex Male Female Male Male Male Male Male
Age class (age in years) Adult (≥ 3) Subadulta (1) Adult (7) Adult (14) Adult (8) Adult (8) Subadult (1.5)
Body weight (kg) 20.5 21 20.1 19.3 15.3 24.8 18.9
Corrected BW (kg) n/a 12 16.7 16.1 n/a n/a n/a
Body condition Excellent Cachexia Cachexia Moderate emaciation Severe emaciation Excellent Good
BW, body weight; n/a, not available. Corrected body weight was obtained after subtracting 1 kg per liter of free fluid (including an approximative amount for subcutaneous edema).
aThe weight was clearly in the adult category (41) and histological examination of the ovaries revealed corpora lutea and follicles in several stages of development (sexually mature
animal) but tooth cementum annuli analysis revealed an age of 17 months (subadult age class).
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FIGURE 2 | Hearts with cardiomegaly and myocardial fibrosis, Eurasian lynx (Lynx lynx carpathicus); (A) case 3, diaphragmatic view: severe cardiomegaly with
rounded profile and marked multifocal fine coalescent light tan striations running across the surface (inset) in absence of coronary fat deposits; (B) case 3, left
ventricle: severe dilation with attenuation of wall thickness and papillary muscles; (C) case 4, left latero-diaphragmatic view: pale color and moderate cardiomegaly,
(Continued)
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FIGURE 2 | uneven surface with variably extensive minimally to mildly depressed areas and discrete multifocal light tan foci (inset); (D) case 4, cross-section:
moderately expanded left ventricle lumen; (E) case 5, diaphragmatic view: moderate cardiomegaly with relatively normal profile and multifocal to coalescent light tan
foci; (F) case 5, cross section: severe dilation of both ventricles; (G) case 6, diaphragmatic view: moderate cardiomegaly with elongated ovoid shape, lateral bulging of
the right ventricle, multifocal to coalescent light tan foci and uneven surface; (H) case 6, cross-section: bilateral ventricular hypertrophy.
FIGURE 3 | Hearts with valvular changes, Eurasian Lynx (Lynx lynx carpathicus); (A) case 3, aortic valve: stenotic fibrotic ridge expanding from, and forming a recess
at the base of, the epicardium, multifocally thickened in the area comprised between the ridge and the semilunar valve (subaortic stenosis); (B) case 4, mitral valve:
multifocal thickening and partial retraction of valvular leaflets with mild to moderate nodular thickenings of the free margins (endocardiosis).
FIGURE 4 | Multisystemic effusions, Eurasian lynx (Lynx lynx carpathicus); (A) case 3, abdominal cavity with severe serosanguinous effusion; (B) case 4, pericardial
sac filled with a moderate amount of clear orange fluid.
French/Swiss border. Case 1 and 2 and the control were≤2 years
old while the other four lynx were ≥7 years old. All were males
except for case 2.
Case 1 was found dead after a field anesthesia with xylazine
and ketamine (34) for fitting a radio-collar in June 1988. This
lynx was apparently healthy but unexpectedly found dead the
next day at the location where it had been left for recovery,
suggesting that it died because of an anesthesia accident shortly
after the manipulations.
Case 2 was found dead. The original diagnosis
of feline infectious peritonitis was not confirmed by
immunohistochemistry (45) and the cause of death remained
unclear. Case 3, 4, and 5 were first anesthetized in the field as
clinically healthy lynx using medetomidine and ketamine (39)
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FIGURE 5 | Extra-cardiac lesions, Eurasian lynx (Lynx lynx carpathicus); (A) case 3, lung; multifocal to coalescent large red foci (atelectasis) and ≪wet-like≫
appearance (edema); (B) case 4, liver; prominent lobular pattern (inset) with diffuse orange to yellow coloration of the parenchyma.
and fitted with a VHF radio-collar (very high frequency or pulse
collar; A. Wagener, Köln, Germany).
Case 3, first captured in September 1999, was recaptured twice
(2 and 4 years after the first capture). At the second capture
in February 2001 it still appeared healthy and was transported
to a quarantine station to be subsequently translocated to
northeastern Switzerland (39, 46). It was in good body condition
(23 kg) and physical examination at capture, blood analyses and
regular direct observations during 2 weeks of quarantine did
not reveal overt sign of illness. During the pre-release clinical
check in March 2001, a soft heart murmur was detected but all
other evaluated health parameters were inconspicuous, including
peripheral pulse, heart rate (56–72 beats/min.), color of oral
mucosa, and capillary refill time (<3 s). The lynx was released
into the wild equipped with a new VHF collar. Radiotelemetry
indicated that it showed a normal, species-specific spatial and
hunting behavior until 15 April 2003, when it was trapped
again and anesthetized with the same protocol to replace
its radio-collar. It showed an abnormally long induction and
recovery times, an elevated heart rate (100–117 beats/min.),
and a delayed capillary refill time (≥3 s) although mucosal
color remained inconspicuous. A video record of the lynx
approaching the trap revealed a severely distended, possibly
oscillating abdomen suggestive of ascites. Considering the heart
murmur noticed 2 years earlier, a presumptive diagnosis of
cardiac circulatory insufficiency wasmade. It recovered well from
the anesthesia, but within 3 weeks after this last capture its health
status progressively deteriorated (abnormal spatial and feeding
behavior after 7 May 2003) until death occurred (found dead on
20 May 2003).
Case 4 was caught in February 1998 and had shown a normal
post-capture spatial and hunting behavior until its radio-collar
stopped working early March 2001. In February 2012 (14 years
after capture) it was found lying close to a road without escape
reaction and therefore assumed to be ill and culled.
Case 5 was in good body condition (24 kg) when captured
mid-March 2013, and all recorded health and anesthesia
parameters were normal except for a heart murmur. It was re-
captured and euthanized 7 weeks later because of abnormal
behavior (apathy and ataxia) and severe emaciation. It developed
respiratory insufficiency during transport but could be stabilized
with an intramuscular injection of 40mg Doxapram (Dopram R©,
Chassot AG, Switzerland) and arrived still alive at the University
of Bern, where it was euthanized. Heart auscultation prior
to euthanasia confirmed the presence of a loud systolic heart
murmur nearly completely covering the heart sounds.
Case 6 was killed in a traffic accident.
Pathology
Case 1, a young individual in excellent body condition, only
showed a severe, acute, bronchoalveolar edema and emphysema,
and moderate fibrosis of the mitral valve. The other five cases
(case 2–6) had cardiomegaly together with multifocal fine light
tan striations coalescing to prominent tan foci in themyocardium
(multifocal myocardial fibrosis). Cardiomegaly was associated
with marked dilation of either the right (case 2) or left ventricle
(case 4), or both (case 3 and 5), while bilateral ventricular
hypertrophy was present in case 6 (Figure 2).
Case 3 additionally had a subaortic stenosis with a distinct
fibrotic ridge running across the left ventricle wall ∼1.5 cm
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FIGURE 6 | Heart, Eurasian lynx (Lynx lynx carpathicus), myocardial fibrosis,
Masson’s trichrome stain (A) Mild to moderate increase of the perivascular
collagen along with mild to moderate intimal thickening and mild multifocal
deposition of collagen between the myofibers; (B) Exuberant collagen is
forming a dense web, entrapping, compressing and replacing several
myofibers; (C) Islands of collagen bridging from the perivascular areas to the
interstitium and replacing large numbers of myofibers.
from the root of the aorta. A diffuse ectasia of the aortic arch
was observed associated with the dilation of the left atrium
and ventricle. The endocardium was thickened, particularly
above the stenotic ring (Figure 3A) and in the left atrium.
Endocardiosis of the mitral valve was observed in case 4
(Figure 3B) and 6.
Case 2–5 showed a decreased body condition, ranging
from moderately emaciated (reduced amount but presence
of intrabdominal and coronary fat) up to cachectic (absence
of coronary fat or serous fat atrophy, together with muscle
atrophy), and they all had an empty stomach indicating the
absence of recent food intake. All four presented with changes
consistent with a right-sided congestive heart failure, including
large amounts of serosanguinous fluid with fibrin deposits
in the abdominal cavity (case 2, 3, and 4; Figure 4A) and
severe diffuse subcutaneous edema (mainly on the caudo-
ventral aspects of the body, case 2 and 3), with additional
diffuse vascular congestion in case 3. There was also serous
effusion in the thoracic cavity (case 2 and 3), and clear light
yellow pericardial effusion (case 3, 4, and 5; Figure 4B). In
case 3–5, the lung showed multifocal to coalescent large foci of
atelectasis (Figure 5A), together with mild edema in the two lynx
with bilateral ventricular dilation (cases 3 and 5). Additionally,
the liver of case 3–5 had a prominent lobular pattern with
increased consistency, along with multifocal darker (case 3)
or diffuse yellow-tan (case 4) coloration (Figure 5B). Kidneys
were congested in two lynx (case 3 and 4) but pale in one
(case 5). Case 2 and 4 had pale mucous membranes suggestive
of anemia.
The heart of case 6, an animal in excellent body condition,
had an ovoid shape with bilateral ventricular hypertrophy
(Figure 2) together with the valvular endocardiosis mentioned
above. Additionally, case 5 showed the outcome of a previous
trauma (healed rib fracture and chronic diaphragmatic hernia
paramedial to the hiatus oesophagicus, with displacement of
20 cm of the omentum major and two thirds of the spleen into
the thorax).
Histological examination of the heart revealed similar
lesions in all six lynx, consisting in mild to severe, multifocal,
interstitial, perivascular and replacement fibrosis (Figures 6, 7)
and Anitschkow cells (Figure 8) in the myocardium along with
multifocal myocyte degeneration and loss. Anitschkow cells
were present mainly in the fibrotic areas of the myocardium
and in the perivascular areas of affected vessels. There was
also moderate to severe multifocal arteriosclerosis with
associated luminal stenosis of the small and medium-sized
intramural coronary arteries (Figures 7, 9) in all cases.
Myointimal cell migration into the adventitia together with
fragmentation and duplication of the internal elastic lamina
was common in the affected tissues (Figures 7, 9). Table 3
presents the cardiac histological changes of the six cases.
Table 4 summarizes the results of the semi-quantitative
evaluation of myocardial fibrosis and arteriosclerosis. In
addition, case 3 showed a neutrophilic epicarditis with edema
and multifocal mild myocyte multinucleation. In contrast to
the others, interstitial fibrosis was more severe in the right
ventricle of this lynx and it was associated with myocyte
degeneration. In case 4, there was a moderate myocyte
degeneration characterized by sarcoplasma vacuolization,
prominent anysocytosis and a mild lymphocytic infiltration.
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FIGURE 7 | Heart, Eurasian lynx (Lynx lynx carpathicus); (A) case 3, H&E stain: Marked thickening of the arterial wall with reduction of the vascular lumen. Multifocal,
mild amount of mucin-like material is observed within the intima and at the interface between the Tunica media and adventitia (Asterisk); (B) case 3, Van Gieson stain:
marked intimal thickening secondary to deposition of collagen fibers (Asterisks) with segmental loss of the internal elastic lamina; (C) Case 3, Masson’s trichrome
stain: Presence of several myointimal cells within the thickened intimal layer (Asterisks); (D) case 3, H&E stain: multifocal interstitial fibrosis with reduction and
replacement of the myofibers; (E) case 3 and (F) case 4, H&E stain: Myocytes with marked pleomorphism (i.e., variable morphology) and variable compression and
distortion by the surrounding connective tissue. Occasional vacuolization of the sarcoplasm along with clear spaces rimming the myocyte profile. Mild to moderate
hypercellularity in the interstitium.
In case 6, mucin-like material embedding variable-extensive
collagen nodules and elastic fibers were found mainly in the
distal part of the mitral leaflet together with hemosiderin-laden
macrophages (endocardiosis). Similar material was also
occasionally observed in between the collagen fibers of the
tunica adventitia.
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Under light microscopy, the lungs revealed the presence
of diffuse edema (interstitial, alveolar, peribronchial and/or
perivascular) and multifocal atelectasis of varying severity in four
lynx each (case 1–3, 5, and case 2–5, respectively). Furthermore,
heart-failure cells were seen in two (case 2 and 3). Additional
findings included a subpleural hemangioma (case 2), multifocal
emphysema (case 1 and 5), mild to moderate hemorrhages
(cases 2 and 6), multifocal mild calcifications (case 4 and 6),
and a mild multifocal histiocytic to lymphocytic interstitial
pneumonia (case 4).
Microscopic liver changes were observed in four lynx
(case 2–5). Three animals showed Ito-cells hyperplasia (case
2–4), with additional moderate to severe hemosiderosis in
case 2 and 3, which were both found dead in a status of
cachexia. Furthermore, the liver of case 3 was characterized
by a severe centrolobular to panlobular fibrosis, together with
multifocal moderate arteriosclerosis and mild cholestasis. In
case 4, there was moderate centrolobular degeneration and
mild centrolobular fibrosis together with mild neutrophilic
and lymphocytic infiltrates, mild hemosiderosis, cholestasis and
sinusoidal dilation.
Additional findings were acute necrotizing pancreatitis with
fibrinous and plasmacellular peripancreatitis (case 2), peritonitis
(case 2 and 3), interstitial edema in the hind leg muscles (case 3),
mild to moderate lymphoid follicle hyperplasia in themesenterial
lymph nodes (case 2), spleen lymphoid depletion (case 3 and 4),
mild membranous glomerulopathy (case 3, 5, and 6), and mild
multifocal lymphoplasmacytic meningitis (case 6).
A comparative summary of the main pathological findings,
data on heart morphology and scoring of histological heart
lesions are presented in Tables 4, 5.
DISCUSSION
This study reveals the existence of previously undescribed cardiac
disorders in Eurasian lynx from a reintroduced population in
Switzerland. The pathological features consistent throughout the
cases were the presence of myocardial fibrosis with associated
Anitschkow cells, and coronary arteriosclerosis with intimal
proliferation, which were pronounced in all lynx except case 2.
Despite inter-individual differences, shared pathological features
suggest that the six lynx were affected by the same disease entity.
While case 1 unexpectedly died during anesthesia and
presented with a severe acute lung edema, case 2–4 had
macroscopic pathological changes characteristics of a congestive
right-sided heart failure. The most advanced disease picture,
including liver fibrosis and congestion, was observed in case 3,
the animal with a subaortic stenosis, which had presented with
a heart murmur at clinical examination and died spontaneously.
Case 4, which was even older but had been culled due to disease
signs, seemed to be in an intermediary position between case 2
and 3 in term of disease severity and chronicity. In line with the
clinicopathological features, relative heart weight and both heart
wall ratios of case 3 and 4 (no available morphologic heart data
for case 2) strongly differed from those of the control animal.
Case 5 (euthanized) and 6 (hit by car) hadmajormacroscopic and
FIGURE 8 | Heart, Eurasian lynx (Lynx lynx carpathicus), H&E stain: Multiple
Anitschkow cells with their characteristic chromatin arrangement (black
arrowheads).
histological cardiac lesions although they died prematurely, but
they presented with fewer (case 5) and no (case 6) major systemic
changes. Accordingly, case 5 may have been in an earlier disease
stage than case 2–4, and disease may have been subclinical in
case 6. In these two last cases, relative heart weight and right/left
ventricular wall ratios were similar to those of the control but they
had bilateral ventricular alterations (dilation and hypertrophy,
respectively), possibly explaining that the wall ratios did not
divergemuch from the control ratio. In case 6, all three walls were
over the average values of adult males without evidence of cardiac
disease, in agreement with a bilateral ventricular hypertrophy,
although the similar relative heart weight was not consistent with
an increased heart mass. It is conceivable that this animal with
hypertrophic heart features may have been at an earlier disease
stage than cases 2–5, which showed heart dilation. In animal
models, concentric myocardial hypertrophy and fibrosis precede
dilation, which marks progression toward decompensated heart
failure and systolic dysfunction (47).
Scores of the histological main lesions were highest in case 5,
followed by case 1 (unexpected death, not assessed by the
authors), 6, 3, and 4, and they were lowest in case 2, not
paralleling the clinicopathological findings. It is known that there
is not necessarily full correspondence between the severity of
gross and microscopic abnormalities within the heart and the
presence of clinical signs attributable to them. While major
structural abnormalities may be found incidentally after death,
there may be relatively mild but critically located lesions resulting
inmarked functional disturbance (48). Sudden cardiac deathmay
occur when the coronary perfusion is impaired (49) or as a result
of ventricular arrhythmias, e.g., in case of (mainly interstitial)
myocardial fibrosis (50). Unexpected death frequently occur
in both animals and humans with subclinical heart disease
(7, 16, 43), meaning that heart disease may be evident only
postmortem (13).
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FIGURE 9 | Heart, Eurasian lynx (Lynx lynx carpathicus), coronary arteriosclerotic lesions, Van Gieson stain (A) case 5: Asymmetrical, mild to moderate thickening of
the media with multifocal variable accumulation of myointimal cells and reduplication of the internal elastic lamina. Multifocal mild to moderate increase of collagen
fibers in the media; (B) case 3: Asymmetrical moderate thickening of the media with abundant collagen deposition and segmental reduplication of the internal elastic
lamina. (C) Case 5: Moderate to severe intimal thickening with moderate proliferation of the myointimal cells, partial reduplication and fragmentation of the internal
elastic lamina and lumen reduction. (D) case 3: Severe intimal thickening with abundant collagen deposition. Moderate increase of collagen also within the media.
(E) case 5: Severe luminal reduction with intimal and medial thickening. Exuberant internal elastic lamina reduplication and fragmentation (F) case 4: Severe intimal
thickening with luminal reduction and moderate myointimal cells proliferation.
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TABLE 3 | Assessment and scoring of the main histopathological features of the
heart of six free-ranging Eurasian lynx (subspecies Lynx lynx carpathicus) from
Switzerland affected by cardiomyopathy.
Lynx case Nr. Vascular Interstitial Myocytes
1 n/a n/a n/a






























Capture procedure and anesthesia likely were stressing factors
in case 1. Anesthesia is a procedure associated with an increased
risk in cardiac patients, whether they present with clinical signs
of heart failure or not. Anesthesia was performed using an alpha-
2 adrenergic drug, a category of sedatives that is considered as
contra-indicated in patients with cardiac disease (51). Alpha2-
adrenoceptor agonist and ketamine combinations provide a
rapid reversible anesthesia but may cause severe sustained
hypertension, putting animals at risk for development of, among
others, pulmonary edema and cardiac failure (52). Therefore,
although case 3 survived the anesthesia despite an advanced stage
of heart failure, subclinical cardiac disease likely predisposed
case 1 to a fatal capture accident. The anesthetic drugs may also
have contributed to the respiratory insufficiency and lung edema
observed in case 5.
The three lynx with chronic heart disease had cardiomegaly
matching the criteria of an eccentric hypertrophy, considering
that the cardiac volume and mass were increased, although the
ventricular free walls were of normal to decreased thickness and
the papillary muscles were attenuated (13, 49). However, the lack
of congestion in the stomach, intestine, spleen and liver (except
for case 3), and the presence of liver fibrosis suggest a more
chronic course in these lynx than typically observed in domestic
animals with congestive heart disease (13). While the last two
cases were older males, case 2 was a young female in the late
growth period. She presented only with a right heart dilation and,
in agreement with her younger age, the apparent absence of liver
involvement pointed at a faster disease course.
Case 1, 3, 4, and 6 had valvular disease additionally to the
lesions in the myocardium and coronary arteries. Subvalvular
aortic stenosis and mitral endocardiosis are common in dogs
but not in cats. They are typically associated with a left-sided
cardiac dysfunction that may end in a congestive heart failure
characterized by interstitial and alveolar pulmonary edema.
Myocardial fibrosis may develop with both valvular pathologies
and may be associated with arteriosclerosis. However, animals
with aortic stenosis are mainly prone to sudden death, and
endocardiosis is a frequent incidental finding at necropsy
(13, 49). While the observed dilation of the aortic arch of case 3
fitted to a post-stenotic dilation of the aorta, the dilation of the left
atrium and ventricle did not fit with the compensatory concentric
hypertrophy (thickening of the ventricular walls) expected in
presence of a subaortic stenosis (13, 49). Differently, dilation
of the left ventricle in case 4 was consistent with the eccentric
hypertrophy (ventricular dilation) expected in atrio-ventricular
valve disease (13). Nevertheless, according to the nearly absent
signs of a left-sided heart failure in the investigated lynx, valvular
abnormalities were considered exacerbating factors in lynx 3 and
4 but not primary etiologies. Since aortic stenoses are a cause
of heart murmur (53), the observed subvalvular stenosis in case
3 may explain the murmur heard at capture. However, this is
not supported by the findings of case 5, who had a murmur
but inconspicuous valves. Myocardial diseases alone are indeed
associated with murmurs (54–56).
All lynx had varying degrees of fibrosis in the myocardium.
Myocardial fibrosis is associated with increased ventricular
stiffness, which compromises ventricular systolic (and diastolic)
function, abnormal cardiac remodeling and development of
ventricular dilation, and activation of compensatory mechanisms
that increase sodium and water retention to increase venous
return to the heart (47, 49, 57, 58). Eccentric myocardial
hypertrophy occurs as a compensatory mechanism to allow the
ventricle to pump a relatively normal amount of blood despite
abnormal systolic function (49). In humans, cardiac fibrosis
is a strong predictor of adverse outcome (57). Therefore, the
observed myocardial lesions are consistent with the observed
disease in the lynx described here and the fatal outcome in case 3.
The origin of the observed myocardial lesions is unknown.
In animals and man, fibrosis is a common feature of most
myocardial diseases. The adult mammalian heart has negligible
regenerative capacity, and once myocytes are lost, there
is progressive scavenging of the necrotic remnants and
replacement by fibrosis, mainly by activation of resident
interstitial myofibroblasts, a process that aims at preserving
the structural integrity of the heart. Pathophysiological
mechanisms leading to fibrosis development are various,
some being acute as in myocardial infarction, others being
progressive. Accordingly, not only cardiomyocyte death
but also injurious stimuli such as pressure and/or volume
overload, metabolic dysfunction, myocardial inflammation, as
well as aging, may cause interstitial and perivascular fibrosis
in the absence of infarction (57). However, the lynx cases
included young individuals still in the growth phase, and no
concurrent disease susceptible to explain the cardiac lesions
were detected at necropsy. Interstitial cardiac fibrosis has been
associated with the delayed peracute syndrome of capture
myopathy described in animals that have experienced an
earlier capture event. However, re-captured animals affected
by this syndrome die within a few minutes. Furthermore,
felids do not belong to the mammals prone to develop capture
myopathy (59), and two of six cases (case 2 and 6) had never
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TABLE 4 | Post-mortem heart findings in six Eurasian lynx (subspecies Lynx lynx carpathicus) from Switzerland affected by cardiomyopathy and a healthy individual
(control) for comparison.
Parameters Case 1 Case 2 Case 3 Case 4 Case 5 Case 6 Control
Clinical findings Heart murmur n/a n/a Yes Yes Yes n/a None
Gross changes Cardiomegaly None RV dilation LV and RV dilation LV dilation LV and RV dilation LV and RV hypertrophy None
Myocardial fibrosis None None Severe Severe Severe Severe None
Valvular changes Mitral EC None Subaortic stenosis Mitral EC None Mitral EC None
Morphometrics Heart weight (g) n/a n/a 130.0 145.5 101.5 129.0 94.0
Relative HW (%)a n/a n/a 0.78 0.90 0.66 0.52 0.50
RV:S:LVb n/a n/a 3:10:5 4:10:7 3:10:8 7:16:20 4:11:13
RV:S:LV ratio n/a n/a 1:3.3:1.7 1:1.7:1.4 1:3.3:2.7 1:2.3:2.9 1:2.8:3.3
RV: LV ratio n/a n/a 0.6 0.57 0.38 0.35 0.31
Histology MF+AS scorec (total) 2 + 3 (5)d 1 + 1 (2) 2 + 2 (4) 1 + 2 (3) 3 + 2.5 (5.5) 2.5 + 2 (4.5) 0 + 0 (0)
EC,endocardiosis; n/a, not applicable.
aHeart weight (HW) / Body weight (BW) in grams x100. The mean ratio HW:BW obtained for apparently healthy Eurasian lynx from Switzerland, based on 10 adult males in good body
condition, was 0.51 (range: 0.45–0.65). The ratio obtained for two cachectic adult males without evidence of clinical cardiac disease was 0.64 and 0.69, respectively. The HW:BW ratio
in healthy Northern lynx was within the same range as for domestic cats (42), i.e., 0.58 ± 0.28–0.88 (13).
bThickness of the right ventricle free wall (RV), interventricular septum (S) and left ventricle free wall (LV) measured in millimeters. For comparison, the mean RV:S:LV ratio for 11 adult
male Eurasian lynx without evidence of clinical cardiac disease was 5:13:15mm (or 1:2.6:3 ratio, i.e., close to the 1:3:3 ratio in healthy domestic cats (16).
cSummary of the semi-quantitative evaluation of myocardial fibrosis (MF) and coronary arteriosclerosis (AS) shown in Table 3.
dScores based on the pathology report descriptions (no archived histological slides or paraffin blocks).
TABLE 5 | Post-mortem findings in other organs than the heart in six Eurasian lynx (subspecies Lynx lynx carpathicus) from Switzerland affected by cardiomyopathy.
Parameters Case 1 Case 2 Case 3 Case 4 Case 5 Case 6
Subcutaneous edema None Severe Severe None None None
Abdominal effusion None Severe Severe Severe None None
Thoracic effusion None Moderate Moderate None None None
Pericardial effusion None None Mild-moderate Moderate-severe Mild None
Lung edema Severe Mild Mild None Moderate None
Lung atelectasis None Mild Moderate-severe Moderate-severe Moderate-severe None
Liver changesa None Mild Severe Mild Mild None
Kidney changesb None None Mild Mild Mild Mild
aProminent lobular pattern and increased consistency (case 2–5); altered liver color (multifocally darker in case 3, and diffuse yellow-tan in case 4); mild to severe hemosiderosis
(case 2–4) and sinusoidal dilation in case 4; Ito-cell activation (case 2–4); mild cholestasis as well as multifocal, moderate arteriosclerosis (case 3); fibrosis (severe and centrolobular to
panlobular in case 3, mild and centrolobular in case 4); moderate centrolobular hepatocyte degeneration as well as mild neutrophilic and lymphocytic inflammation (case 4).
bMild congestion (case 3 and 4); mild color alteration (pale, case 5); mild membranous glomerulopathy (case 3, 5, 6).
experienced a capture, while the control had been anesthetized
multiple times.
Another feature of the lynx cardiomyopathy was coronary
arteriosclerosis. Arteriosclerosis, or chronic arterial stenosis, has
been described in multiple animal species including dogs and
cats, swine, bovine, monkeys and mice (60, 61). It usually results
from proliferative and degenerative changes and is common
in domestic animals, with age-related increasing frequency and
severity. Despite being often an incidental, clinically irrelevant
finding, it is frequently associated with heart diseases, e.g., in
dogs with mitral valve disorders and cats with HCM, cats and
dogs withChlamydia sp. infection, and dogs experiencing sudden
death (60).
Although arteriosclerosis and myocardial fibrosis can occur
independently from each other (60), myocardial infarction and
coronary arteriosclerosis are principal causes of heart failure
in humans, and there is increasing evidence of an association
of myocardial fibrosis and arterial lesions in both animals and
humans, with fibrosis believed to result from ischemia caused by
arterial stenosis (60–65). Accordingly, arteriosclerosis may have
been the cause of myocardial injury and replacement fibrosis in
the lynx.
Following pathological examination of case 3, we conducted
a pilot study on the histopathology of Swiss lynx hearts using
archived H&E slides. We compared them with a small number
of H&E slides from Swedish lynx (Northern lynx) and found
a significant difference in prevalence of combined myocardial
fibrosis and arteriosclerosis (65.8 and 23.8%, respectively), which
affected mainly adult males (66). In a second phase of this pilot
study we used a larger sample size from both countries, processed
all samples in the same laboratory and used VG instead of
H&E stain. In this second sample set, the mentioned histological
anomalies occurred at a prevalence close to 70% in both countries
while moderate and severe lesions were most common in the
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Swiss Alps, suggesting that mild arteriosclerosis and myocard
fibrosis are common in Eurasian lynx but supporting the data of
the first study phase as concerns the difference between Sweden
and Switzerland. Furthermore, the differences with the first
phase of our study demonstrated the importance of harmonized
methods to conduct proper comparisons (67). Interestingly, a
subsequent study in lynx from Finland underlined the existence
of population-related differences even more, as minimal to mild
fibrosis was detected in 56% of 63 Northern lynx heart but
arteriosclerosis was never observed (42).
We found Anitschkow cells in all six lynx, differently from
animals without evidence of cardiac disease, including the
control animal. Anitschkow cells are characteristic mononuclear
cells with “caterpillar” - like nuclei, which are usually observed
in the myocardium and in coronary vessel walls and may
representmodifiedmyocytes. They are typically found in humans
affected by rheumatic heart disease and other cardiac pathologies,
and in animals of various species with myocarditis, myocardial
necrosis, degenerative and inflammatory endocardial diseases,
or arteriosclerosis (13, 60, 68). Accordingly, the presence of
Anitschkow cells may also be linked to myocardial disorders
in lynx.
Given the absence of obvious signs of infection (blood
values and clinical observations, pathological findings) in all
studied lynx, a genetic origin of this cardiomyopathy should
be considered. Genetic factors are increasingly recognized
as a cause of cardiac disorders, including cardiomyopathies
with and without associated intramural coronary artery wall
abnormalities (2, 4, 69). For example, genetic anomalies have
been associated with HCM in cats and humans (21, 69, 70),
DCM in cattle, dogs and humans (2, 4, 71, 72) and other
cardiomyopathies in various species, including animal models
such as mice and rhesus macaques (73). The six affected lynx
came from the same population, which has undergone a severe
population bottleneck and is characterized by a reduced level
of heterozygocity (37, 74). Although these six cases are few
compared to the mortality recorded in lynx in Switzerland (311
lynx submitted to necropsy from 1987 to 2019), diseased wild
animals are less likely to be discovered compared to those that
die of anthropogenic causes and are therefore underrepresented
in necropsy material (45, 75). This may be particularly true
for animals experiencing sudden cardiac death. The repeated
occurrence of a yet undescribed disease in the reintroduced Swiss
lynx population deserves attention, especially considering that
genetic threats to small isolated populations are gradual processes
that show long-term effects (26). As a genetic origin of the
observed conditions would have serious consequences on on-
going conservation programs in Europe, this hypothesis warrants
further investigations.
In conclusion, the investigated lynx were affected by a
myocardial disease with coronary arteriosclerosis, potentially
leading either to unexpected death or to a right-sided congestive
heart failure, and associated with a heart murmur in the
two cases that could be examined clinically. Heart function
was likely further compromised by valvular disorders in four
of six cases. As the heart alterations did not match any
of the three main cardiomyopathy categories (HCM, DCM,
RCM), they must be regarded as a cardiomyopathy of non-
specified phenotype with potential genetic background. The cases
presented here span over 20 years, illustrating the value of long-
term health monitoring of reintroduced wildlife populations
and of performing necropsies on wild animals that die during
capture events. This study also highlights the importance of
veterinary investigations and standardized necropsy protocols in
the framework of conservation programs.
DATA AVAILABILITY STATEMENT
The original contributions presented in the study are included
in the article, further inquiries can be directed to the
corresponding author/s.
ETHICS STATEMENT
Ethical review and approval was not required for the animal
study because investigations were performed on dead animals
submitted to necropsy. Data previously collected on live animals
were obtained in the framework of ecological studies run
independently of the present study and conducted with the
necessary authorizations of the Swiss cantonal ethics committees
according to the Swiss law on animal experiments.
AUTHOR CONTRIBUTIONS
M-PR-D designed, performed the study, and wrote the
manuscript. NR and FO provided pathology expertise and
contributed to pathology data collection. FO described the
histological pictures. M-PR-D, MP, and RM carried out clinical
examinations. M-PR-D, SZ-G, and RM performed necropsies.
UB initiated veterinary examinations of lynx in Switzerland,
coordinated the ecological projects, and contributed to field
work. AR organized the captures and radio-tracked the lynx.
AK provided cardiology expertise and performed an in-depth
cardiological examination of the control animal. All authors
critically read and approved the manuscript.
FUNDING
All investigations were performed in the framework of projects
mandated and financially supported by the Swiss Federal Office
of the Environment.
ACKNOWLEDGMENTS
Many thanks go to all collaborators of the KORA and FIWI
who provided assistance during captures or necropsies, to the
staff of the Clinical Laboratory of the University of Zurich for
blood sample analyses, to the Clinical Radiology unit of the
Department of Clinical Veterinary Medicine, University of Bern,
for the radiographs of the control lynx, and to the technical
personnel of the histology laboratory of the Vetsuisse Faculty,
University of Bern, for processing histological slides.
Frontiers in Veterinary Science | www.frontiersin.org 14 December 2020 | Volume 7 | Article 594952
Ryser-Degiorgis et al. Cardiomyopathy in Eurasian Lynx
REFERENCES
1. Barquera S, Pedroza-Tobías A, Medina C, Hernández-Barrera L, Bibbins-
Domingo K, Lozano R, et al. Global overview of the epidemiology of
atherosclerotic cardiovascular disease. Arch Med Res. (2015) 46:328–38.
doi: 10.1016/j.arcmed.2015.06.006
2. Owczarek-Lipska M, Plattet P, Zipperle L, Drögemüller C, Posthaus H, Dolf
G, et al. A nonsense mutation in the optic atrophy 3 gene (OPA3) causes
dilated cardiomyopathy in Red Holstein cattle. Genomics. (2011) 97:51–7.
doi: 10.1016/j.ygeno.2010.09.005
3. Shyu J-J, Cheng C-H, Erlandson RA, Lin J-H, Liu S-K. Ultrastructure of
intramural coronary arteries in pigs with hypertrophic cardiomyopathy.
Cardiovasc Pathol. (2002) 11:104–11. doi: 10.1016/S1054-8807(01)00101-6
4. Stern JA, Ueda Y. Inherited cardiomyopathies in veterinary medicine. Pflugers
Arch. (2019) 471:745–53. doi: 10.1007/s00424-018-2209-x
5. Daigneault M, Harr KE, Dean KM, Bursian SJ. Assay validation of the
cardiac isoform of troponin I in double crested cormorant (Phalacrocorax
auritus) plasma for diagnosis of cardiac damage. Ecotoxicol Environ Saf.
(2017) 141:52–6. doi: 10.1016/j.ecoenv.2017.03.006
6. Flanders JA, Buoscio DA, Jacobs BA, Gamble KC. Retrospective
analysis of adult-onset cardiac disease in François’ langurs
(Trachypithecus Francoisi) housed in US zoos. J Zoo Wildl Med. (2016)
47:717–30. doi: 10.1638/2015-0119.1
7. Lowenstine LJ, McManamon R, Terio KA. Comparative pathology of aging
great apes: bonobos, chimpanzees, gorillas, and orangutans.Vet Pathol. (2016)
53:250–76. doi: 10.1177/0300985815612154
8. Raymond JT, Garner MM. Cardiomyopathy in captive African
hedgehogs (Atelerix albiventris). J Vet Diagn Invest. (2000)
12:468–72. doi: 10.1177/104063870001200516
9. Roth L, King JM. Congestive cardiomyopathy in the woodchuck, Marmota
monax. J Wildl Dis. (1986) 22:533–7. doi: 10.7589/0090-3558-22.4.533
10. Schilliger L, Chetboul V, Damoiseaux C, Nicolier A. Restrictive
cardiomyopathy and secondary congestive heart failure in a McDowell’s
carpet python (Morelia spiloty McDowelli). J Zoo Wildl Med. (2016)
47:1101–4. doi: 10.1638/2016-0076.1
11. Fox PR, Basso C, Thiene G, Maron BJ. Spontaneously occurring
restrictive nonhypertrophied cardiomyopathy in domestic cats: a
new animal model of human disease. Cardiovasc Pathol. (2014)
23:28–34. doi: 10.1016/j.carpath.2013.08.001
12. Norton BB, Tunseth D, Holder K, Briggs M, C Hayek L-A, Murray S. Causes
of morbidity in captive African lions (Panthera leo) in North America,
2001-2016. Zoo Biol. (2018) 37:354–9. doi: 10.1002/zoo.21435
13. Robinson WF, Robinson NA. Cardiovascular system. In: Grant Maxie M,
editors. Jubb, Kennedy, and Palmer’s Pathology of Domestic Animals, 6th Edn.
St. Louis, Missouri, TX: Elsevier (2016). p. 2–91.
14. Brieler J, Breeden MA, Tucker J. Cardiomyopathy: an overview. Am Fam
Physician. (2017) 96:640–6. Available online at: https://www.aafp.org/afp/
2017/1115/afp20171115p640.pdf
15. Luis Fuentes V, Abbott J, Chetboul V, Côté E, Fox PR, Häggström J, et
al. ACVIM consensus statement guidelines for the classification, diagnosis,
and management of cardiomyopathies in cats. J Vet Intern Med. (2020)
34:1062–77. doi: 10.1111/jvim.15745
16. Wilkie LJ, Smith K, Luis Fuentes V. Cardiac pathology findings in
252 cats presented for necropsy; a comparison of cats with unexpected
death vs. other deaths. J Vet Cardiol. (2015) 17(Suppl. 1):S329–40.
doi: 10.1016/j.jvc.2015.09.006
17. Fox PR. Hypertrophic cardiomyopathy. Clinical and pathologic correlates. J
Vet Cardiol. (2003) 5:39–45. doi: 10.1016/S1760-2734(06)70051-0
18. Fox PR, Keene BW, Lamb K, Schober KA, Chetboul V, Luis Fuentes V, et al.
International collaborative study to assess cardiovascular risk and evaluate
long-term health in cats with preclinical hypertrophic cardiomyopathy and
apparently healthy cats: the REVEAL study. J Vet Intern Med. (2018)
32:930–43. doi: 10.1111/jvim.15285
19. Paige CF, Abbott JA, Elvinger F, Pyle RL. Prevalence of cardiomyopathy
in apparently healthy cats. J Am Vet Med Assoc. (2009)
234:1398–403. doi: 10.2460/javma.234.11.1398
20. Ironside VA, Tricklebank PR, Boswood A. Risk indictors in cats with
preclinical hypertrophic cardiomyopathy: a prospective cohort study. J Feline
Med Surg. (2020) 1–11. doi: 10.1177/1098612X20938651
21. Hensley N, Dietrich J, Nyhan D, Mitter N, Yee M-S, Brady M.
Hypertrophic cardiomyopathy: a review. Anesth Analg. (2015)
120:554–69. doi: 10.1213/ANE.0000000000000538
22. Maron BJ, Udelson JE, Bonow RO, Nishimura RA, Ackerman MJ, Estes NA
III, et al. Eligibility and disqualification recommendations for competitive
athletes with cardiovascular abnormalities: Task Force 3: hypertrophic
cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy
and other cardiomyopathies, and myocarditis. Circulation. (2015)
132:e273–80. doi: 10.1161/CIR.0000000000000239
23. Chapron G, Kaczensky P, Linnell JDC, von Arx M, Huber D, Andrén H,
et al. Recovery of large carnivores in Europe’s modern human-dominated
landscapes. Science. (2014) 346:1517–9. doi: 10.1126/science.1257553
24. Andrén H, Linnell JDC, Liberg O, Andersen R, Danell A, Karlsson
J, et al. Survival rates and causes of mortality in Eurasian
lynx (Lynx lynx) in multi-use landscapes. Biol Conserv. (2006)
131:23–32. doi: 10.1016/j.biocon.2006.01.025
25. Molinari-Jobin A, Marboutin E, Wölfl S, Wölfl M, Molinari P, Fasel M, et
al. Recovery of the Alpine lynx Lynx lynx metapopulation. Oryx. (2010)
44:267–75. doi: 10.1017/S0030605309991013
26. Keller LF,Waller DM. Inbreeding effects in wild populations. Trends Ecol Evol.
(2002) 17:230–41. doi: 10.1016/S0169-5347(02)02489-8
27. Schmidt K, Ratkiewicz M, Konopiński MK. The importance of genetic
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